Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing oilseed Camelina to produce proprietary products; and high value seed traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
IPO Year: 2006
Exchange: NASDAQ
Website: yield10bio.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/8/2024 | Buy → Hold | Lake Street | |
3/10/2022 | $18.00 → $9.00 | Buy | Maxim Group |
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)
Lake Street downgraded Yield10 Bioscience from Buy to Hold
Maxim Group reiterated coverage of Yield10 Bioscience with a rating of Buy and set a new price target of $9.00 from $18.00 previously
Maxim Group reiterated coverage of Yield10 Bioscience with a rating of Buy and set a new price target of $24.00 from $12.00 previously
8-K - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
8-K - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
8-K - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
8-K - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
DEFM14A - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
8-K - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
PREM14A - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
8-K - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
10-Q - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
424B3 - YIELD10 BIOSCIENCE, INC. (0001121702) (Filer)
WOBURN, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Willie Loh, Ph.D., was named to the Company's Board of Directors effective October 4, 2022. Dr. Loh previously served as a Special Commercial and Technical Advisor to the Company. Dr. Loh was formerly Vice President, Market Development of Cargill Inc.'s Global Edible Oils Solutions group in North America. Cargill is a global food and agriculture company. "We are delighted that Willie is expanding his role with Yield10 by serving on our Board of Directors," said Oliver Peoples, Ph.D., Chief Executive Officer of Yield1